Tempest Therapeutics, Inc. (TPST)
0.89
-0.02
(-2.08%)
USD |
NASDAQ |
Sep 10, 10:12
Tempest Therapeutics Market Cap : 14.22M for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 14.52M |
| September 08, 2026 | 15.77M |
| September 04, 2026 | 16.46M |
| September 03, 2026 | 16.78M |
| September 02, 2026 | 17.58M |
| September 01, 2026 | 16.78M |
| August 31, 2026 | 17.42M |
| August 28, 2026 | 16.94M |
| August 27, 2026 | 17.26M |
| August 26, 2026 | 17.26M |
| August 25, 2026 | 17.74M |
| August 24, 2026 | 17.58M |
| August 21, 2026 | 16.62M |
| August 20, 2026 | 16.30M |
| August 19, 2026 | 17.10M |
| August 18, 2026 | 17.10M |
| August 17, 2026 | 18.06M |
| August 14, 2026 | 16.22M |
| August 13, 2026 | 18.70M |
| August 12, 2026 | 19.34M |
| August 11, 2026 | 18.86M |
| August 10, 2026 | 14.92M |
| August 07, 2026 | 13.15M |
| August 06, 2026 | 12.94M |
| August 05, 2026 | 13.11M |
| Date | Value |
|---|---|
| August 04, 2026 | 12.73M |
| August 03, 2026 | 12.55M |
| July 31, 2026 | 12.28M |
| July 30, 2026 | 12.39M |
| July 29, 2026 | 12.80M |
| July 28, 2026 | 12.49M |
| July 27, 2026 | 13.41M |
| July 24, 2026 | 13.28M |
| July 23, 2026 | 13.49M |
| July 22, 2026 | 13.64M |
| July 21, 2026 | 14.20M |
| July 20, 2026 | 13.66M |
| July 17, 2026 | 13.86M |
| July 16, 2026 | 14.00M |
| July 15, 2026 | 15.35M |
| July 14, 2026 | 14.06M |
| July 13, 2026 | 14.11M |
| July 10, 2026 | 13.96M |
| July 09, 2026 | 13.98M |
| July 08, 2026 | 14.16M |
| July 07, 2026 | 14.21M |
| July 06, 2026 | 15.35M |
| July 02, 2026 | 15.64M |
| July 01, 2026 | 15.92M |
| June 30, 2026 | 15.92M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.761B |
| Alnylam Pharmaceuticals, Inc. | 33.74B |
| Anika Therapeutics, Inc. | 282.11M |
| Savara, Inc. | 1.092B |
| Vericel Corp. | 1.952B |
Market Cap Related Metrics
| Price | 0.89 |
| Earnings Yield | -503.9% |